About Bioversa International
Bioversa International is a private limited company (BV/SRL) based in Ukkel, founded in 2021. Equity is negative (-€809): liabilities exceed assets. 2 annual accounts are available, covering 2022 to 2023.
- Signals
-
Negative equityNegative equity € -809
Equity is negative: debts exceed assets (technically insolvent).
Poor liquidityPoor liquidity 0.00The current ratio is below 1: may be insufficient to cover short-term debt.
Financial ratios
|
|
2023
|
2022
|
|---|---|---|
|
€
-809
|
€
-809
|
|
|
Solvability
|
|
|
|
€
809
|
€
809
|
|
|
Cash
|
|
|
Publications 6
All publications- Capital, Actions - Demissions, Nominations 14/10/2024
- N Bce 08/04/2024
- N Bce 01/03/2024
- Capital, Actions - Demissions, Nominations 01/12/2023
- Demissions, Nominations 30/06/2022
Frequently asked questions
Answers to the most common questions about Bioversa International, based on official government data and the filed annual accounts.
What is the VAT number of Bioversa International?
The VAT number of Bioversa International is BE0774.905.878.
When was Bioversa International established?
Bioversa International was founded in 01-10-2021.
What is the official address of Bioversa International?
The official address of Bioversa International is Kersbeeklaan 308 Ukkel 1180.
What is the legal form of Bioversa International?
The juridical form of Bioversa International is Private limited company (BV/SRL).
What is the annual revenue of Bioversa International?
The 2023 accounts of Bioversa International do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
Is Bioversa International a reliable company?
Bioversa International is a registered Rechtspersoon with company number 0774.905.878 and can be verified through the official CBE database.
What is the credit limit of Bioversa International?
The estimated credit limit of Bioversa International is €0.
Is Bioversa International still active?
Bioversa International currently has the status "Normal situation" and is active.